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L E T T E R  T O  T H E  E D I T O R
Inhibition of β-catenin/CBP signalling improves airway 
epithelial barrier function and suppresses CCL20 release
To the editor
The airway epithelial barrier in asthma may be more susceptible to 
damage and/or less capable of repair in response to aeroallergens 
like house dust mite (HDM), resulting in loss of barrier function, 
as evidenced by reduced expression of cell-cell adhesion protein 
E-cadherin.1 This may not only lead to increased permeability to 
allergens and impaired epithelial differentiation, but also result in 
increased pro-inflammatory responses, including the release of cy-
tokines such as CCL20, GM-CSF, CCL17, IL-33 and TSLP to attract 
and activate immune cells.2 Epithelial cells from asthma patients 
display a more basal phenotype than healthy epithelium, along with 
an inability to re-differentiate into a functionally intact epithelium 
and reconstitute normal barrier function upon damage by allergens.3 
The loss of E-cadherin releases β-catenin, which translocates to the 
nucleus, inducing divergent gene expression profiles depending on 
recruitment of different transcriptional co-activators. Recruitment 
of CREB-binding protein (CBP) results in expression of genes associ-
ated with epithelial de-differentiation, migration and proliferation, 
while p300 induces gene transcription associated with cell differen-
tiation.4 We previously observed that epithelial exposure to HDM 
results in E-cadherin and β-catenin loss from adherens junctions, 
accompanied by increased CCL20 release, and that asthma-derived 
airway epithelial cells are more susceptible to these HDM-induced 
effects. It is currently unknown whether dysregulated β-catenin sig-
nalling contributes to this abnormal epithelial phenotype in asthma.
We hypothesized that binding of β-catenin to p300 suppresses 
pro-inflammatory responses and improves epithelial barrier func-
tion. We tested this by pharmacological inhibition of β-catenin/CBP 
activity using ICG-001, a highly specific inhibitor of β-catenin/CBP 
binding promoting β-catenin/p300 binding,5 in human primary air-
way epithelial cells (PAECs). We assessed effects on HDM-induced 
CCL20 release and barrier function at baseline and after injury.
We first investigated whether β-catenin/CBP signalling reg-
ulates epithelial pro-inflammatory responses by quantifying the 
effect of ICG-001 on HDM-induced CCL20 release. HDM signifi-
cantly increased CCL20 production in PAECs obtained by bronchial 
brushings from both asthma and healthy donors (Figure 1A,C). As 
there was no significant difference in HDM-induced CCL20 increase 
between PAECs from asthma (4.4 ± 2.0-fold) and healthy donors 
(2.9 ± 1.1-fold), we combined the groups to assess the effect of 
ICG-001. Pretreatment with ICG-001 significantly decreased the 
HDM-induced CCL20 release in the combined group of asthma and 
heathy donors (0.48 ± 0.35-fold, Figure 1B,D). Similar effects were 
observed for GM-CSF (Figure S1A,B), where ICG-001 significantly 
reduced basal and HDM-induced GM-CSF levels, while CCL17, TSLP 
and IL-33 were not detectable. Furthermore, a similar effect of HDM 
on CCL20 was observed in PAECs derived from human tracheobron-
chial tissue of normal lung transplant donors, with a trend towards 
inhibition of HDM-induced CCL20 levels by ICG-001 (Figure S1C,D).
We next investigated if ICG-001 treatment improves epithelial 
barrier function, a hypothesized prerequisite for epithelial differ-
entiation, in PAECs derived from human bronchial tissue of nor-
mal lung transplant donors because of the limited availability of 
PAECs from the bronchial brushings from asthma and healthy do-
nors. Electric resistance was measured as read-out for epithelial 
barrier function using Electric Cell-substrate Impedance Sensing 
(ECIS), a highly accurate technique for real-time monitoring of cell 
adhesion/spreading, barrier function and wound healing.6 While 
low-frequency resistance is most sensitive for changes in cell-cell 
contacts, high-frequency capacitance is more sensitive for changes 
in cell-substrate contacts. Low-frequency resistance, stabilizing at 
2572.4 ± 294.9 Ω upon hormone/growth factor deprivation, signifi-
cantly increased after addition of ICG-001 (~1.5-fold), which was 
evident within 6 hours and lasted up to 30 hours (Figure 2A). The 
high-frequency capacitance altered to a lesser extent (Figure 2B), 
indicating that this effect is primarily due to increased cell-cell adhe-
sion. We next investigated if ICG-001 promotes epithelial cell repair 
after injury induced by electroporation, using 5 V pulses at 40 kHz 
for 30 seconds, resulting in almost complete detachment of the cells 
from the electrode.6 This was reflected by an immediate decrease 
in resistance (Figure 2C) and comparable increase in capacitance 
(Figure 2D), followed by migration of cells over the wounded area, as 
evident from the increase in resistance and decrease in capacitance, 
restoring the integrity of the monolayer within ~3 hours. While 
3-hour pretreatment with ICG-001 did not affect this initial repair 
response, ICG-001 further enhanced low-frequency resistance once 
capacitance stabilized, indicating increased recovery of cell-cell con-
tacts (Figure 2C,D).
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Because of the limited PAEC numbers, we used human bronchial ep-
ithelial 16HBE cells for further mechanistic studies. We observed that 
in 16HBE both HDM and thapsigargin increased the release of CCL20, 
which was inhibited by ICG-001 pretreatment (Figure S2A,B). ICG-001 
did not reduce CCL20 mRNA expression (Figure S2C-F), indicating that 
ICG-001 inhibits HDM-induced CCL20 release through post-transcrip-
tional regulation. Indeed, ICG-001 still inhibited CCL20 release upon 
inhibition of de novo synthesis using cycloheximide (Figure S3A,B). 
Of note, disrupting cortical actin filaments, and thus localization of 
E-cadherin at cell-cell contacts, by cytochalasin D significantly increased 
CCL20 release, with a trend towards inhibition by ICG-001 (Figure S3C).
As for the mechanisms of barrier function, we previously ob-
served that 16HBE barrier function is comparable to that of differ-
entiated PAECs.6 We used thapsigargin to induce barrier damage, 
a sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) inhibitor that 
mimics the Ca2+-mediated effects of HDM,2 yet causing a more 
robust effect. Thapsigargin induced a similar decrease in 16HBE 
barrier function (Figure S4C) as observed for electroporation in 
PAECs. ICG-001 increased barrier function at baseline and im-
proved recovery from thapsigargin-induced damage (Figure S4). 
This was accompanied by a significant increase in the localization 
of E-cadherin to cell-cell contacts, which may be regulated by the 
F I G U R E  1   ICG-001 inhibits HDM-induced CCL20 production in PAECs. PAECs were obtained by bronchial brushings from healthy 
(n = 6) and asthmatic (n = 6) donors. Cells were seeded in duplicates at a density of 5 × 104 cells/well in a 24-well plate, grown to confluence, 
growth factor/hormone deprived overnight, pretreated with 10 µM of ICG-001/vehicle control for 3 h, followed by 50 µg/mL HDM. Cell-free 
supernatants were collected after 24 hours, and protein levels of CCL20 were measured. CCL20 levels are presented as absolute values (pg/mL) 
(A, B) or as percentage of the unstimulated levels (C, D). CCL20 levels in separate (A, C), and in combined group (B, D) of asthma and healthy-
derived PAECs. Data are presented as median ± IQR, and Friedman test was used to determine the statistical significance; *P < .05, ***P < .001
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organization of the actin cytoskeleton and cortical expression of 
F-actin (Figure S5A-C). Accordingly, blocking actin polymerization 
using cytochalasin D caused a transient decrease in barrier func-
tion, with a disorganized actin network and junctional disruption 
of E-cadherin, which could at least in part be mitigated by ICG-
001 (Figure S5D,E). Collectively, these data suggest that ICG-001 
may improve epithelial barrier function by increasing β-catenin re-
cycling to adherens junctions to form a complex with E-cadherin 
and the actin cytoskeleton. We previously showed that junctional 
E-cadherin loss leads to increased EGFR activity,7 which can induce 
Ca2+ signalling and subsequently activate ADAM10, a well-known 
sheddase of E-cadherin.8 Our current data suggest that inhibi-
tion of CCL20 release by ICG-001 may be mediated by stabilizing 
E-cadherin at the membrane, inhibiting EGFR activity,7 Ca+2 signal-
ling and subsequent ADAM10 activation (Figure S6), which we have 
previously shown to be involved in CCL20 release.9 Further studies 
are currently being directed towards investigating the effect of in-
hibition of the β-catenin/CBP pathway on barrier function and mu-
cociliary differentiation of PAECs from healthy and asthma donors 
cultured at air-liquid interface.
F I G U R E  2   ICG-001 increases the epithelial barrier function in PAECs. PAECs were obtained from human bronchial tissue of normal 
lung transplant donors (n = 6). Cells were seeded in duplicates at a density of 5 × 104 cells/well in 8-well electrode arrays connected to ECIS 
system, grown to confluence for 3 days, growth factor/hormone deprived overnight, and pretreated with 10 µM of ICG-001 or vehicle 
control for 3 h. (A) Resistance and (B) capacitance values were normalized to the time point of addition of ICG-001. After 3 h, the cells were 
wounding by electroporation. (C) Resistance and (D) capacitance values were normalized to the lowest and highest points respectively after 
wounding. Data are presented as mean ± SEM, and two-way ANOVA was used to determine the statistical significance; *P < .05
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In conclusion, our data show that inhibition of β-catenin/CBP sig-
nalling promotes cell-cell contacts and recovery of epithelial barrier 
function upon damage, while attenuating CCL20 release after HDM ex-
posure. Interference of β-catenin/CBP signalling may constitute a novel 
treatment strategy aimed at the restoration of the mucosal barrier in 
asthma and protection against pro-inflammatory activity in asthma.
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